- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01503996
Drinking Habits of Glaucoma Patients and Age Matched Controls
Clinical Study to Evaluate the Drinking Habits of Glaucoma Patients and Age Matched Controls
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Glaucoma patients who are hospitalized for diurnal intraocular pressure measurements and glaucoma assessment are asked about their drinking habits. Objective evaluation of hydration status is assessed with the Body Composition Monitor (Fresenius). Retinal Vessel Analysis and Laser Doppler Flowmetry are investigated in subgroups.
The control group are also hospitalized patients who do not suffer from glaucoma.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Dresden, Germany, 01307
- University Eye Clinic Dresden
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Glaucoma patients who are hospitalized for diurnal intraocular pressure measurements and glaucoma assessment.
Controls who are hospitalizes because of an other ophthalmic disease and do not suffer from glaucoma.
Description
Inclusion Criteria:
- glaucoma patients
- controls
Exclusion Criteria:
- psychiatric disease,
- epilepsy, pregnancy,
- nutritional disorder,
- malfunction of blood clotting and wound healing,
- pacemaker,
- metallic stents
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
glaucoma
hospitalized glaucoma patients
|
if dehydration is apparent, more fluid intake is recommended
|
|
controls
hospitalized patients without glaucoma
|
if dehydration is apparent, more fluid intake is recommended
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dehydration
Time Frame: 4 years
|
The composition of a patient's body, in particular a patient's water content are determined with bioimpedance spectroscopy (Body Composition Monitor, FRESENIUS)
|
4 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
microvascular changes
Time Frame: 4 years
|
To investigate differences in retinal vessel diameters measured with the Retinal Vessel Analyzer (RVA, IMEDOS) in glaucoma patients and controls
|
4 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Karin R Pillunat, MD, University Eye Clinic Dresden
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Drinking/Glaucoma
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.